Oral pentoxifylline combined with pentavalent antimony: A randomized trial for mucosal leishmaniasis

Clinical Infectious Diseases

Volumn 44, Issue 6, 2007, Pages 788-793

  Machado, Paulo R L ^a   Lassa, Hélio ^a   Lessa, Marcus ^a   Guimarǎes, Luiz H ^a   Bang, Heejung ^b   Ho, John L ^b   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; MEGLUMINE ANTIMONATE; PENTOXIFYLLINE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LEISHMANIASIS; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TISSUE INJURY; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADULT; ANTIMONY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; PENTOXIFYLLINE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33847625958     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/511643     Document Type: Article

References (28)

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27:305-18.
2. Jones TC, Johnson WD Jr, Barreto AC, et al. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156:73-83.
3. Marsden PD. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Très Braços, Bahia-Brazil. Rev Soc Bras Med Trop 1994; 27:93-101.
4. Berman JD. Chemotherapy for leishmaniasis; biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1988; 10:560-86.
5. Franke ED, Wignall FS, Cruz ME, et al. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990; 113:934-40.
6. Netto EM, Marsden PD, Llanos-Cuentas EA, et al. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with glucantime. Trans R Soc Trap Med Hyg 1990; 84:367-70.
7. Bittencourt AL, Andrade ZA. Immunopathological aspects of mucocutaneous leishmaniasis. Hospital (Rio J) 1967; 71:975-84.
8. Ribeiro de Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998;31:143-8.
9. Da-Cruz AM, Oliveira MP, De Luca PM, Mendonça SCF, Coutinho SG. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1996; 91:225-9.
10. Castes M, Trujilo O, Rojas ME, et al. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res 1993; 26:233-8.
11. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceiç̃o- Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993; 91:1390-5.
12. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th-1 responses in mucosal leishmaniais patients. Infect Immun 2002; 70:6734-40.
13. Lessa HA, Machado P, Lima F, et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001; 65:87-9.
14. Reed SG, Badaro R, Masur H, et al. Selection of a skin test antigen for American cutaneous leishmaniasis. Am J Trop Med Hyg 1986; 35:79-85.
15. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp, Infect Immun 2002; 70:2288-96.
16. Carvalho EM, Johnson WD, Barreto E, et al. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985; 135:4144-8.
17. Mendonca MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 2004; 189:1018-23.
18. Aimeida R, D'Oliveira A Jr, Machado P, et al. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis. J Infect Dis 1999; 180:1735-7.
19. Santos JB, de Jesus AR, Machado PR, et al. Antimony plus recombinant human granulocyte-macrophagecolony-stimulatingfactorapplied topically in low doses enhances healing of cutaneous leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study. J Infect Dis 2004; 190:1793-6.
20. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34:50-98.
21. Das BK, Mishra S, Padhi PK, et al. Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults. Trop Med Int Health 2003; 8:680-4.
22. Gutierrez-Reyes G, Lopez-Ortal P, Sixtos S, et al. Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C. Scand J Immunol 2006; 63:461-7.
23. Ustunsoy H, Sivrikoz MC, Tarakcioglu M, Bakir K, Guldur E, Celkan MA. The effects of pentoxifylline on the myocardial inflammation and ischemia-reperfusion injury during cardiopulmonary bypass. J Card Surg 2006;21:57-61.
24. Bafica A, Oliveira F, Freitas LA, Nascimento EG, Barrai A. American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Im J Dermatol 2003;42:203-7.
25. Sadeghian G, Nilforoushzadeh MA. Effect of combination therapy with systemic Glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Int J Dermatol 2006; 45:819-21.
26. Doherty GM, Jensen JC, Alexander HR, Buresh CM, Norton JA. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110:192-8.
27. Sarno EN, Grau GE, Vieira IMM, Nery JAC. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol 1991; 84:103-8.
28. De Carsalade GY, Achirafi A, Flageul B. Pentoxifylline in the treatment of erythema nodosum leprosum. J Dermatol 2003; 30:64-8.